Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
255.8 BRL | +0.13% | -.--% | +13.50% |
05-29 | Nicotine-like chemicals in U.S. vapes may be more potent than nicotine, FDA says | RE |
05-29 | Nicotine-like chemicals in U.S. vapes may be more potent than nicotine, FDA says | RE |
Evolution of the average Target Price on Philip Morris International, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Philip Morris International, Inc.
Jefferies & Co. | |
Stifel Nicolaus | |
SBG Securities | |
Consumer Edge | |
Argus | |
JPMorgan Chase | |
Societe Generale | |
UBS | |
Morgan Stanley | |
Morningstar | |
Redburn | |
Goldman Sachs | |
Barclays | |
Citigroup | |
Credit Suisse | |
BofA Securities | |
Deutsche Bank Securities | |
Piper Sandler | |
J.P. Morgan Chase | |
Bernstein | |
JPMORGAN | Celine Pannuti |
EPS Revisions
- Stock Market
- Equities
- PM Stock
- PHMO34 Stock
- Consensus Philip Morris International, Inc.